During the past decade, CHA Gangnam Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHA Gangnam Medical Center" #1 sponsor was "CHA University" with 11 trials, followed by "Korean Gynecologic Oncology Group" with 3 trials sponsored, "BioLeaders Corporation" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Genexine, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHA Gangnam Medical Center" #1 collaborator was "CHA University" with 1 trials as a collaborator and "Seoul St. Mary's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CHA Gangnam Medical Center" are "Benign Uterine Disease" (2 trials), "Cervical Intraepithelial Neoplasia" (2 trials), "Endometrial Hyperplasia" (2 trials), "Uterine Myomas" (2 trials) and "Cervical Intraepithelial Neoplasia Grade 2/3" (1 trials). Many other conditions were trialed in "CHA Gangnam Medical Center" in a lesser frequency.

Most popular intervention types in "CHA Gangnam Medical Center" are "Procedure" (8 trials), "Drug" (7 trials), "Biological" (2 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BLS-ILB-E710c" (1 trials), "Bipolar coagulation" (1 trials), "Combined home visiting and group intervention" (1 trials) and "Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHA Gangnam Medical Center" are 20 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "CHA Gangnam Medical Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in CHA Gangnam Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CHA Gangnam Medical Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".